HJ1.F Core Laboratories Inc.
- Market cap
- EUR 355M
- P/E
- 26.7x
- P/B
- 1.38x
- ROE
- 5.1%
- Dividend yield
- 0.48%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is HJ1.F undervalued?
Graham numberHJ1.F trades 27.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Core Laboratories Inc. fundamental analysis
No fundamental analysis for Core Laboratories Inc. yet.
Core Laboratories Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Core Laboratories Inc.
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It o…
Full company profileCore Laboratories Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Core Laboratories Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 490M | 510M | 524M | 527M | 505M |
| Gross Profit | 78.9M | 94.0M | 88.4M | 94.3M | 78.2M |
| Operating Income | 41.3M | 56.2M | 49.8M | 50.5M | 28.9M |
| EBITDA | 58.7M | 70.4M | 73.5M | 71.1M | 45.9M |
| Net Income | 19.5M | 36.7M | 31.4M | 29.7M | 14.1M |
| EPS | 0.42 | 0.78 | 0.67 | 0.64 | 0.31 |
| Balance Sheet | |||||
| Total Assets | 578M | 586M | 590M | 584M | 594M |
| Total Liabilities | 389M | 357M | 333M | 312M | 309M |
| Shareholders' Equity | 184M | 225M | 252M | 266M | 278M |
| Cash & Short-term Investments | 15.4M | 15.1M | 19.2M | 22.7M | 21.4M |
| Cash Flow | |||||
| Operating Cash Flow | 25.0M | 24.8M | 56.4M | 37.0M | 22.3M |
| Capital Expenditure | 10.2M | 10.6M | 13.0M | 14.7M | 19.2M |
| Free Cash Flow | 14.7M | 14.2M | 43.4M | 22.3M | 3.16M |
| Ratios | |||||
| ROE | 10.6% | 16.3% | 12.5% | 11.2% | 5.1% |
| ROA | 3.4% | 6.3% | 5.3% | 5.1% | 2.4% |
| Net Profit Margin | 4.0% | 7.2% | 6.0% | 5.6% | 2.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Core Laboratories Inc. dividends
- Dividend yield
- 0.48%
- Forward dividend
- 0.04 EUR
- Payout ratio
- 6.3%
- Ex-dividend date
- Nov 9, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 1.87M | 0.04 | 6.3% |
| 2024 | USD 1.88M | 0.04 | 6.0% |
| 2023 | USD 1.87M | 0.04 | 5.1% |
| 2022 | USD 1.85M | 0.04 | 9.5% |
| 2021 | USD 1.83M | 0.04 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jul 9, 2010.
Who owns Core Laboratories Inc.
- Insiders 1.44%
- Institutions 98.57%
- Public & others 0.00%
- Shares outstanding 45.8M
- Free float 45.2M
Core Laboratories Inc. company profile
- Company name
- Core Laboratories Inc.
- Ticker
- HJ1.F
- Exchange
- Frankfurt Exchange
- Sector
- Energy
- Industry
- Oil & Gas Equipment & Services
- Employees
- 3,300
- Fiscal year end
- December
- Address
- 6316 Windfern Road, Houston, TX, United States, 77040
- Phone
- 713 328 2673
- Website
- corelab.com
About Core Laboratories Inc.
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Core Laboratories Inc. management
6- Mr. Lawrence V. BrunoChairman of the Board, CEO, President & COO · born 1960
- Mr. Christopher Scott HillSenior VP & CFO · born 1970
- Ms. Gwendolyn Y. Gresham M.B.A.Senior Vice President of Corporate Development & Investor Relations · born 1968
- Mr. Mark Damian Tattoli J.D.Senior VP, Secretary & General Counsel · born 1972
- Mr. Sow Hang TeoVP, Treasurer & Chief Accounting Officer · born 1970
- Leslie D. LinklaterVice President of People, Organization & Culture